Compounds of formula (I) as well as pharmaceutically acceptable salts and esters thereof, wherein R1 to R4 have the significance given in claim 1 can be used in the form of pharmaceutical compositions.
申请公布号
CA2612740(C)
申请公布日期
2011.07.26
申请号
CA20062612740
申请日期
2006.06.26
申请人
F. HOFFMANN-LA ROCHE AG
发明人
AMREIN, KURT;HUNZIKER, DANIEL;KUHN, BERND;MAYWEG, ALEXANDER V.;NEIDHART, WERNER
